Exagen Inc. XGN Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Exagen Inc.’s reported figures.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Exagen Inc.'s invested capital?
- Exagen Inc. (XGN) reported invested capital of $19.87M in Q1 2026.
- How has Exagen Inc.'s invested capital changed year-over-year?
- Exagen Inc.'s invested capital increased by 7.7% year-over-year, from $18.45M to $19.87M.
- What is the long-term trend for Exagen Inc.'s invested capital?
- Over 5 years (2020 to 2025), Exagen Inc.'s invested capital has grown at a -1.1% compound annual growth rate (CAGR), from $13.41M to $12.7M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).